913983-33-2 Usage
Uses
Used in Pharmaceutical Research and Development:
3-IODO-5-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE is used as a key intermediate in the synthesis of various pharmaceutical compounds for the treatment of different diseases. Its unique structure and properties make it a valuable component in the development of novel drugs with improved efficacy and safety profiles.
Used in Chemical Research:
In the field of chemical research, 3-IODO-5-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE serves as a versatile building block for the creation of new chemical entities. Its reactivity and functional groups allow for various chemical transformations, enabling the synthesis of a wide range of organic and inorganic compounds with diverse applications.
Used in Material Science:
3-IODO-5-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE is employed as a component in the development of advanced materials with specific properties. Its incorporation into polymers, coatings, and other materials can enhance their performance, durability, and functionality in various applications, such as electronics, aerospace, and automotive industries.
Check Digit Verification of cas no
The CAS Registry Mumber 913983-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,9,8 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 913983-33:
(8*9)+(7*1)+(6*3)+(5*9)+(4*8)+(3*3)+(2*3)+(1*3)=192
192 % 10 = 2
So 913983-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7IN2O/c1-12-5-2-6-7(9)4-11-8(6)10-3-5/h2-4H,1H3,(H,10,11)
913983-33-2Relevant academic research and scientific papers
WDR5 INHIBITORS AND MODULATORS
-
Paragraph 00225, (2021/05/15)
Isoquinolmone compounds and derivatives inhibit WDR5 and associated protein-protein interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation.
Compounds and methods for kinase modulation, and indications therefor
-
Page/Page column 92, (2015/09/22)
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereo
JNK inhibitors
-
Page/Page column 52, (2010/11/25)
The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neu
Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
-
Page/Page column 51, (2010/11/26)
The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neu
